Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis

Table 2

OX40 and OX40L expression in patients with MG at baseline and healthy controls.

Group	Membrane-bound molecules				Soluble molecules
	No.	CD4^+OX40^+ (%)	CD19^+OX40L^+ (%)	CD14^+OX40L^+ (%)	No.	sOX40 (pg/ml)	sOX40L (ng/ml)
MG at baseline	39	6.20 (3.48, 9.43)	67.30 (57.45, 74.25)	82.00 (78.35, 89.75)	37
HC	36	2.27 (1.32, 3.95)	58.15 (50.70, 63.70)	78.25 (71.80, 85.50)	30
Test of value		-4.311	-2.535	-2.222		-6.529	0.576
value		≤0.001	0.011	0.026		≤0.001	0.566